In addition, CLDN6 overexpression may act as an oncogene and enhance HepG2 cell migration, invasion, and proliferation via EGFR/AKT/mTOR signaling in hepatocellular carcinoma (46). The gene discussed is CLDN6; the disease is hepatocellular carcinoma.